| 2026-09-15 | 8-K | Form 8-K, Item 5.02 |
| 2026-08-17 | Press release | Ventas Releases 2025-2026 Corporate Sustainability Report |
| 2026-07-30 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-29 | Supplement | Supplemental Information Provided July 29, 2026 |
| 2026-07-29 | Press release | Press release · Q2 2026 · Jul 2026 |
| 2026-07-29 | 8-K | Form 8-K, Item 2.02 results |
| 2026-06-29 | Press release | Download PDFVentas Announces Second Quarter 2026 Earnings Release Date and Conference Call in PDF format"(opens in new w |
| 2026-06-22 | Press release | Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research |
| 2026-06-15 | 8-K | Form 8-K, Item 5.02 |
| 2026-06-03 | Press release | Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement |
| 2026-06-01 | Press release | Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit’s REITweek 2026 Investor Conference |
| 2026-06-01 | Deck | Investor presentation · Jun 2026 |
| 2026-05-15 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-13 | Press release | Ventas Declares Quarterly Dividend of $0.52 Per Common Share |
| 2026-05-13 | Proxy | 2026 PROXY STATEMENT of 2025 Annual Report |
| 2026-04-28 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-27 | Press release | Ventas Announces First Quarter 2026 Earnings Release Date and Conference Call |
| 2026-04-27 | Press release | Press Release of Q1 2026 |
| 2026-04-27 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-27 | Transcript | Q1 FY26 earnings call transcript |
| 2026-04-02 | Press release | Download PDFVentas Announces First Quarter 2026 Earnings Release Date and Conference Call in PDF format"(opens in new wi |
| 2026-04-01 | Annual report | 2025 Annual Report of 2025 Annual Report |
| 2026-04-01 | Proxy | Definitive proxy statement |
| 2026-03-03 | Press release | Ventas Issues Investor Presentation for Upcoming Investor Conferences |
| 2026-03-02 | Press release | Ventas Issues Investor Presentation for Upcoming Investor Conferences |
| 2026-02-20 | 8-K | Form 8-K, Item 5.02 |
| 2026-02-09 | 8-K | Form 8-K, Item 8.01 |
| 2026-02-06 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-05 | Supplement | Supplemental Information Provided February 5, 2026 |
| 2026-02-05 | Press release | Download PDFVentas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend in PD |
| 2026-02-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-20 | Press release | Ventas Announces Tax Treatment of 2025 Distributions |
| 2026-01-14 | Press release | Download PDFVentas Announces Fourth Quarter 2025 Earnings Release Date and Conference Call in PDF format"(opens in new w |
| 2026-01-07 | 8-K | Form 8-K, Item 1.01 |
| 2025-12-08 | Deck | Investor presentation · Dec 2025 |
| 2025-12-04 | 8-K | Form 8-K, Item 8.01 |
| 2025-11-17 | 8-K | Form 8-K, Item 5.02 |
| 2025-10-30 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-30 | Transcript | Q3 FY25 earnings call transcript |
| 2025-10-29 | Supplement | Supplemental Information 3Q25 · Q3 2025 |